Wednesday, December 24, 2025

Tag: Cytokinetics

This Cytokinetics Director Sold 5,000 Shares in November. Is It Time to Dump the Biopharmaceutical Stock?

Cytokinetics is a late-stage biopharmaceutical company targeting muscle function. Its stock...